United States - English - NLM (National Library of Medicine)

aurora pharmaceutical, inc. - sodium salicylate (unii: wiq1h85syp) (salicylic acid - unii:o414pz4lpz) - sodium salicylate 48.6 g in 100 ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - sodium salicylate - parenteral liquid/solution/suspension - sodium salicylate phenol active 250.0 mg/ml - musculoskeletal system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - anti-inflammatory agent | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - phenylbutazone; sodium salicylate - parenteral liquid/solution/suspension - phenylbutazone analgesic active 186.0 mg/ml; sodium salicylate phenol active 50.0 mg/ml - musculoskeletal system - dog | horse | horse foal | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses - analgesic | anti-inflammatory agent | musculoskeletal conditions | antipyretic | arthritis | arthrosis | bone soreness | bruising | bursitis | colic | external myopathy | inflamation of soft tissues an | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteitis | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon and ligament sprains | tendon sprains | tendonitis | tenosynovitis | traumatic joint and connective | traumatic swelling

United States - English - NLM (National Library of Medicine)

international medication systems, limited - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis – e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time int

United States - English - NLM (National Library of Medicine)

aurora pharmaceutical, inc. - sodium salicylate (unii: wiq1h85syp) (salicylic acid - unii:o414pz4lpz), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - sodium salicylate 60 g in 100 ml - for use in the drinking water of poultry and swine as an aid in reducing pain, fever and inflammation.

Ireland - English - HPRA (Health Products Regulatory Authority)

dopharma research b.v. - sodium salicylate - powder for oral solution - 800 milligram(s)/gram - sodium salicylate - cattle, pigs - n.s.a.i.d.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - sodium salicylate - unknown - sodium salicylate phenol active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - sodium salicylate - unknown - sodium salicylate phenol active 0.0 - active constituent

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - potassium chloride, quantity: 0.3 g/l; magnesium chloride hexahydrate, quantity: 0.3 g/l; sodium chloride, quantity: 6.02 g/l; sodium acetate trihydrate, quantity: 4.63 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - ionolyte is indicated for:,- mild metabolic acidosis,- as a source of water and electrolytes